Evidence map›Paper›PMID 29572206›Full record

ArticleCirculation research2018

Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion.

Grégory Franck, Thomas L Mawson, Eduardo J Folco, Roberto Molinaro, Victoria Ruvkun, Daniel Engelbertsen, Xin Liu, Yevgenia Tesmenitsky, Eugenia Shvartz, Galina K Sukhova and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 181 papers.

0numbers the graph read from it
0cells of the map it votes in
181citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

181 citing papers in PubMed, 285 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Distinct types of regulated cell death in atherosclerosis.Journal of pharmaceutical analysis · 2026
    Review
  12. Review
  13. Review
  14. Pathogenesis of plaque erosion.Trends in cardiovascular medicine · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

121 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Commented on by
    A2018
5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Grégory FranckFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Thomas L MawsonFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Eduardo J FolcoFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Roberto MolinaroFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Victoria RuvkunFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Daniel EngelbertsenDepartment of Pathology (D.E., A.L.).
Xin LiuFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Yevgenia TesmenitskyFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Eugenia ShvartzFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Galina K SukhovaFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Jean-Baptiste MichelBrigham and Women's Hospital, Harvard Medical School, Boston, MA; INSERM U1148, Laboratory for Vascular Translational Science (LVTS), Paris, France (G.F., J.-B.M., A.N.).
Antonino NicolettiBrigham and Women's Hospital, Harvard Medical School, Boston, MA; INSERM U1148, Laboratory for Vascular Translational Science (LVTS), Paris, France (G.F., J.-B.M., A.N.).
Andrew LichtmanDepartment of Pathology (D.E., A.L.).
Denisa WagnerDivision of Hematology/Oncology, Boston Children's Hospital, MA (D.W.).
Kevin J CroceFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.).
Peter LibbyFrom the Department of Cardiovascular Medicine (G.F., T.L.M., E.J.F., R.M., V.R., X.L., Y.T., E.S., G.K.S., K.J.C., P.L.) plibby@bwh.harvard.edu.
Anna Needs Neuroblastoma Answers · USBrigham and Women's Hospital · USInserm · FR

Funding

How inflammation and thrombosis fuel disease and aging: Focus on NETsR35HL135765 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI WAGNER, DENISA D · 2017 to 2023
$6.2M
Molecular Determinants of Arterial Remodeling in AtherogenesisR01HL080472 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2005 to 2018
$5.0M
NHLBI NIH HHS R01 HL080472NHLBI NIH HHS R35 HL135765
6 · The paper itself

Abstract

rationaleNeutrophils likely contribute to the thrombotic complications of human atheromata. In particular, neutrophil extracellular traps (NETs) could exacerbate local inflammation and amplify and propagate arterial intimal injury and thrombosis. PAD4 (peptidyl arginine deiminase 4) participates in NET formation, but an understanding of this enzyme's role in atherothrombosis remains scant.

objectiveThis study tested the hypothesis that PAD4 and NETs influence experimental atherogenesis and in processes implicated in superficial erosion, a form of plaque complication we previously associated with NETs. METHODS AND

resultsBone marrow chimeric

conclusionsThese results indicate that PAD4 from bone marrow-derived cells and NETs do not influence chronic experimental atherogenesis, but participate causally in acute thrombotic complications of intimal lesions that recapitulate features of superficial erosion.

Indexed as

AnimalsBone Marrow TransplantationCarotid Artery DiseasesCell DeathDeoxyribonuclease IExtracellular TrapsHumansHydrolasesMaleMiceMice, Inbred C57BLNeutrophilsOsteomyelitisPlaque, AtheroscleroticProtein-Arginine Deiminase Type 4ThrombosisDeoxyribonuclease IHydrolasespeptidylarginine deiminase 4, mouseProtein-Arginine Deiminase Type 4acute coronary syndromeatherosclerosisendothelial cellsgranulocytesthrombosis

Identifiers

PMID29572206
PMCPMC6014872
OpenAlexW2791819435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.